Condition

Lymphoblastic Lymphoma clinical trials and research

• 21Clinical trials
• 11Countries

Newest Lymphoblastic Lymphoma clinical trials

All recruiting trials (21)

• Strength Training for Kids with Acute Lymphoblastic Leukemia and Lymphoblastic L lymphoma

  Researchers are testing a structured strength-training program for children and teens recently diagnosed with ALL or lymphoblastic lymphoma to see if it helps with weight gain and physical function during treatment.

  Recruiting UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07634653

• First-in-human testing of 4A10 for relapsed or hard-to-treat ALL and lymphoblastic lymphoma

  This early-stage trial tests a new antibody therapy called 4A10 in patients with relapsed or hard-to-treat acute lymphoblastic leukemia or lymphoblastic lymphoma to see if it is safe and how the body handles it.

  Recruiting at 5 sites Phase 1 Allterum Therapeutics, Inc · Aurora, Colorado and 6 other locations · NCT07586618

• Child and Young Adult (CAYA) Cancer Outcomes Review

  This project looks at past treatment results to see what affects outcomes for children and young adults (ages 0–21) with leukemia and other cancers treated at participating centers in low- and middle-income countries.

  Recruiting at 5 sites Resonance, Inc. · Yerevan and 6 other locations · NCT07246213

• Dose‑adjusted EPOCH chemotherapy with or without rituximab plus ponatinib for newly diagnosed Philadelphia chromosome–positive B‑cell ALL/lymphoblastic lymphoma

  This treatment plan tests whether adding the BCR‑ABL inhibitor ponatinib to dose‑adjusted EPOCH chemotherapy, with rituximab for CD20‑positive disease, helps adults newly diagnosed with Philadelphia chromosome–positive B‑cell acute lymphoblastic leukemia or lymphoblastic lymphoma.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT07224100

• CMV Triplex vaccine to boost immunity and prevent CMV after haploidentical stem cell transplant

  This trial tests whether giving a CMV-MVA Triplex vaccine to donors and/or recipients, with or without the antiviral letermovir, can boost CMV immunity and prevent CMV viremia in people having haploidentical stem cell transplants.

  Recruiting at 3 sites Phase 1 City of Hope Medical Center · Duarte, California and 2 other locations · NCT07020533

• Erwinia asparaginase with chemotherapy for high‑risk adults with newly diagnosed Philadelphia‑negative acute lymphoblastic leukemia or lymphoblastic lymphoma

  This trial tries Erwinia-derived asparaginase together with induction and consolidation chemotherapy in adults 18–54 with newly diagnosed high‑risk, Philadelphia chromosome–negative ALL or lymphoblastic lymphoma.

  Recruiting at 4 sites Phase 2 City of Hope Medical Center · Phoenix, Arizona and 7 other locations · NCT06918431

• New treatment for children and young adults with newly diagnosed B-cell leukemia and lymphoma

  This study is testing if two new treatments can help children and young adults with newly diagnosed B-cell leukemia and lymphoma achieve better remission results than older therapies.

  Recruiting at 3 sites Phase 2 St. Jude Children's Research Hospital · Charlotte, North Carolina and 2 other locations · NCT06533748

• WU-CART-007 anti-CD7 CAR-T for relapsed or MRD-positive T-cell ALL and lymphoblastic lymphoma

  This trial will try WU-CART-007, an off-the-shelf anti-CD7 CAR-T therapy, in people with relapsed/refractory or MRD-positive T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma to see if it produces MRD-negative remissions.

  Recruiting at 18 sites Phase 2 Allotera Therapeutics · Duarte, California and 17 other locations · NCT06514794

• Vitamin A and D supplementation for patients undergoing allogeneic hematopoietic transplantation

  This study is testing if giving high doses of vitamins A and D before a stem cell transplant can help patients with certain blood cancers have fewer complications like infections and graft-versus-host disease.

  Recruiting Phase 2 St. Petersburg State Pavlov Medical University · Saint Petersburg · NCT06508099

• Comparing two conditioning regimens for haploidentical stem cell transplantation

  This study is testing two different treatment plans for patients getting stem cell transplants from partially matched donors to see which one works better in preventing complications like graft failure and relapse.

  Recruiting Phase 2 St. Petersburg State Pavlov Medical University · Saint Petersburg · NCT06477549

• Treatment for Chronic Lymphocytic Leukemia using modified T cells

  This study is testing a new treatment using modified T cells to see if it can help people with chronic lymphocytic leukemia that hasn't responded to other therapies.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06364423

• Identifying treatment needs for newly diagnosed acute leukemia and lymphoma

  This study is testing a new 7-day chemotherapy treatment for people newly diagnosed with acute lymphoblastic leukemia, lymphoblastic lymphoma, or mixed phenotype acute leukemia to see how well it works and to better understand their risk of recurrence.

  Recruiting at 5 sites Phase 4 St. Jude Children's Research Hospital · San Diego, California and 4 other locations · NCT06289673

• Investigating a new drug combination for relapsed acute lymphoblastic leukemia

  This study is testing a new combination of drugs to see if it can safely help patients with relapsed acute lymphoblastic leukemia feel better and improve their treatment outcomes.

  Recruiting at 2 sites Phase 1/2 University of Chicago · Chicago, Illinois and 1 other locations · NCT06207123

• Targeted T-Cell and B-Cell Depletion for Hematologic Malignancies

  This study is testing a new way to prepare patients with blood cancers for stem cell transplants by removing certain immune cells to see if it helps them recover better and stay healthy longer.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT05794880

• T cell receptor depletion for blood cancer treatment

  This study is testing a new way to treat blood cancers by using a special treatment before a stem cell transplant to see if it helps both kids and adults do better after the procedure.

  Recruiting Phase 2 Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT05735717

• Using Tagraxofusp to treat pediatric patients with relapsed or refractory blood cancers

  This study is testing a new drug called Tagraxofusp to see if it can help children and young adults with tough-to-treat blood cancers feel better and improve their chances of recovery.

  Recruiting at 15 sites Phase 1 Therapeutic Advances in Childhood Leukemia Consortium · Los Angeles, California and 30 other locations · NCT05476770

• Donor stem cell transplant with chemotherapy and radiation for blood cancers

  This study is testing if a donor stem cell transplant combined with different doses of chemotherapy and radiation can help people with blood cancers recover better.

  Recruiting Phase 2 Fred Hutchinson Cancer Center · Seattle, Washington · NCT04195633

• Mobile app to help teens and young adults take their daily oral leukemia medicine

  This project tests a smartphone app that sends tailored reminders and messages to help adolescents and young adults with acute lymphoblastic leukemia or lymphoblastic lymphoma take their daily 6-mercaptopurine during maintenance therapy.

  Recruiting Northwestern University · Chicago, Illinois · NCT03932903

• Using CD45RA Depleted Stem Cells to Improve Immune Recovery After Transplant

  This study is testing if using special stem cells can help patients with acute leukemia recover their immune system faster after a transplant and reduce the risk of complications.

  Recruiting Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT03810196

• Hematopoietic stem cell transplant for blood cancers

  This study is testing two different ways of doing stem cell transplants for people with blood cancers to see which method works better and is safer.

  Recruiting Phase 2 Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT03314974

• Effects of dexrazoxane on heart health in cancer survivors

  This study tests if the drug dexrazoxane can help protect the heart health of cancer survivors who had leukemia, lymphoma, or osteosarcoma.

  Recruiting at 62 sites Children's Oncology Group · Birmingham, Alabama and 78 other locations · NCT01790152

Related topics

Quick answers

How many Lymphoblastic Lymphoma clinical trials are recruiting right now?

21, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in United States (18 trials), Australia (3 trials), Russia (2 trials), Canada (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 9, Phase 1: 3, Phase 1/2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →